StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ODYY

Odyssey Health, Inc.

ODYY OTC Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.01
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$707K
Revenue (TTM)
$0.00
Net income (TTM)
-$3.57M
EPS (TTM)
$-0.03
P/E ratio
Dividend yield
Free cash flow
Cash
$298K
Total assets
$374K
Gross margin
52-week range
$0.00 – $0.13

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-04-30 Jun 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation May 26, 2026 8-K Entered a material agreement May 11, 2026 8-K Entered a material agreement; Other events Apr 24, 2026 10-Q Quarter ended 2026-01-31 Mar 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation Feb 3, 2026 10-Q Quarter ended 2025-10-31 Dec 11, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 19, 2025 10-K Fiscal year ended 2025-07-31 Oct 29, 2025 8-K Entered a material agreement; Other events Oct 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Oct 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation Oct 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 22, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 13, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 4, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 4, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jul 11, 2025 10-Q Quarter ended 2025-04-30 Jun 13, 2025 8-K Other events May 29, 2025 10-Q Quarter ended 2025-01-31 Mar 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation Feb 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation Feb 6, 2025 10-Q Quarter ended 2024-10-31 Dec 16, 2024 10-K Fiscal year ended 2024-07-31 Nov 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 23, 2024 10-Q Quarter ended 2024-04-30 Jun 14, 2024 10-Q Quarter ended 2024-01-31 Mar 22, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jan 5, 2024 8-K Completed an acquisition or disposition Dec 29, 2023 10-Q Quarter ended 2023-10-31 Dec 15, 2023 8-K Regulation FD disclosure; Other events Dec 13, 2023 8-K Shareholder vote results Dec 7, 2023 10-K/A Fiscal year ended 2023-07-31 Nov 28, 2023 8-K Entered a material agreement; Took on a direct financial obligation Nov 2, 2023 10-K Fiscal year ended 2023-07-31 Oct 30, 2023 8-K Director or officer change Oct 6, 2023 8-K Entered a material agreement; Other events Oct 5, 2023 8-K Entered a material agreement; Took on a direct financial obligation Aug 18, 2023